This event is archived. Final snapshot from when the story concluded. View on Dashboard
Regulatory securities lawsuit

TransMedics faces securities fraud lawsuit

Analysis based on 7 articles · First reported Feb 26, 2025 · Last updated Apr 10, 2025

Sentiment
-70
Attention
4
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market is negatively impacted by the allegations of fraud and unsafe practices against TransMedics, leading to a significant drop in TransMedics' stock price. This event highlights increased regulatory risk for companies in the medical device industry.

Medical devices Legal services

Faruqi & Faruqi, a national securities law firm, is investigating and leading a federal securities class action lawsuit against TransMedics. The lawsuit alleges that TransMedics engaged in kickbacks, fraudulent overbilling, coercive tactics, and unsafe practices, while also hiding safety issues and lacking proper oversight. These allegations stem from a report issued by Scorpion Capital on January 10, 2025, which described TransMedics' business model as an 'extreme and grotesque healthcare fraud.' Following the report, TransMedics' stock fell 5.15% on January 10, 2025, and an additional 6.9% on January 13, 2025. Investors who suffered losses between February 23, 2023, and January 10, 2025, are encouraged to contact Faruqi & Faruqi, with a deadline of April 15, 2025, to seek the role of lead plaintiff.

100 Faruqi & Faruqi filed class action TransMedics
95 TransMedics stock fell
90 Scorpion Capital issued report TransMedics
stock
TransMedics is facing a federal securities class action lawsuit alleging fraud, unsafe practices, and lack of safety oversight, which has caused its stock price to fall.
Importance 100.0 Sentiment -80.0
priv
Scorpion Capital issued a report on January 10, 2025, alleging extreme healthcare fraud by TransMedics, which triggered the stock price drop and subsequent lawsuit.
Importance 70.0 Sentiment 60.0
priv
Importance 0.0 Sentiment 0.0
per
Importance 0.0 Sentiment 0.0
TransMedics target Scorpion Capital TransMedics is the target of an activist short campaign by Scorpion Capital, which has publicly accused the company of u
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.